BioSpace News Archive

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other cancers, today announced that David Arthur, CEO of Salarius Pharmaceuticals, will present during the Diamond Equity Research Emerging Growth Invitational 2022 Virtual Conference.

PolarityTE, Inc. today announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S. Application No. 17/326,734 filed on May 21, 2021 .

ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships.

EvoEndo®, Inc. has announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to begin marketing and sale of the EvoEndo® Single-Use Endoscopy System.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the approval of four generic injectables products.

Paragon 28, Inc. announced it will report financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 8, 2022.

Nexus Spine today announced the appointment of Steve Cichy as Vice President of Sales.

POINT Biopharma Global Inc., a company accelerating the discovery, development and global access to life-changing radiopharmaceuticals, announced that the Company’s Chief Executive Officer, Dr. Joe McCann will participate in the following upcoming investor conferences.

Entera Bio Ltd today announced that the Company’s Chief Executive Officer, Spiros Jamas, Sc.D., will present a company overview at the Aegis Capital Corp. Virtual Conference on February 23rd at 3:30 PM Eastern time.

Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced positive outcomes from an additional research study conducted for GIMOTI® nasal spray.